Acute chest pain (ACP) is a prevalent symptom in clinical practice, often indicative of potentially life-threatening conditions such as acute coronary syndrome (ACS) or pulmonary embolism. However, it may also stem from benign causes, necessitating a careful and systematic diagnostic approach.
ACP evaluation commences with a thorough history and physical examination. The aim is to identify high-risk features suggestive of ACS, including pain characteristics, associated symptoms, risk factors, and prior cardiac history. Concurrently, vital signs and physical findings can hint at alternative diagnoses, like aortic dissection or pericarditis.
Electrocardiogram (ECG) is the first-line diagnostic test, performed promptly to detect ST-segment elevation myocardial infarction (STEMI). Non-diagnostic ECGs do not exclude ACS and warrant further testing. Cardiac biomarkers, primarily high-sensitivity troponins, are invaluable in ACS diagnosis, with serial measurements recommended in the first 3 hours from symptom onset.
Chest X-ray, while typically normal in ACS, can reveal alternative diagnoses like pneumonia or pneumothorax. Computed tomography (CT) angiography is the imaging modality of choice for suspected pulmonary embolism or aortic dissection. Coronary CT angiography can also be used in low-risk patients to rule out coronary artery disease.
Risk stratification tools, such as the HEART score, guide further management. Low-risk patients might undergo stress testing or advanced imaging, while high-risk patients require hospitalization and invasive strategies.
ACP presents a diagnostic challenge, necessitating a systematic approach to distinguish serious from benign causes. A comprehensive history and physical examination, combined with judicious use of diagnostic tests and risk stratification tools, are pivotal in guiding management and improving patient outcomes. Continued research and technological advancements promise to refine this process further, enhancing our ability to accurately diagnose and treat this common clinical presentation.
1.
Imetelstat for MDS-relateret anemia er godkendt af Food and Drug Administrations panel.
2.
Navigating breast cancer diagnosis, treatment, and survivorship in Ethiopia
3.
No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire
4.
Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy
5.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
1.
Ferroptosis as a Therapeutic Target in Cancer
2.
Subchorionic Hematoma: Causes, Symptoms, and Treatment
3.
Adaptive Cell Therapies for Solid Tumors
4.
Engineered Niches for Blood-Cell Regeneration: Current Concepts and Clinical Implications
5.
Unlocking the Potential of Hemin: A Novel Approach to Health and Wellbeing
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation